Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Misses Revenue Estimates
AGIOAgios Pharmaceuticals(AGIO) Zacks Investment Research·2024-02-15 22:26

Agios Pharmaceuticals (AGIO) came out with a quarterly loss of 1.72pershareversustheZacksConsensusEstimateofalossof1.72 per share versus the Zacks Consensus Estimate of a loss of 1.64. This compares to earnings of 0.67pershareayearago.Thesefiguresareadjustedfornonrecurringitems.Thisquarterlyreportrepresentsanearningssurpriseof4.880.67 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -4.88%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of 1.69 per share when it actually produced a loss of $1.64, delivering a surprise of 2.96%. Over the last four quart ...